Preliminary report suggests lapse in manufacturing process at Maiden Pharma

The firm has been in news for supplying contaminated cough syrups to Gambia, which is linked to the deaths of 66 children due to the presence of contaminants

Delhi-based Maiden Pharmaceuticals may be in trouble as a preliminary report by the Haryana state drug authorities and the Central Drugs Standards Control Organisation (CDSCO) has shown violations of good manufacturing practices (GMP) by the firm.

The government sources confirmed that a preliminary report has been submitted to the Union Health Ministry based on the visits made by the regulatory authorities to the company’s factory premises in Sonepat, Haryana.

The laboratory test results of the samples collected from the facility are, however, awaited. The samples have been sent to Central Drugs Laboratory, Kolkata. The government officials from CDSCO visited their